Table 4 Univariate and multivariate analysis of prognostic factors regarding progression free survival and overall survival
From: Tailored radiotherapeutic strategies for disseminated uterine cervical cancer patients
Prognostic factor | No. of patients | Univariate analysis | Multivariate analysis | ||||||
|---|---|---|---|---|---|---|---|---|---|
5-y Survival rate (%) | PFS | OS | |||||||
PFS | p-value | OS | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | ||
Age (y) | NS | NS | — | — | — | — | |||
≤50 | 29 | 27.2 | 34.5 | ||||||
>50 | 21 | 30.6 | 35.9 | ||||||
Pathology | NS | NS | — | — | — | — | |||
SCCa | 42 | 27.5 | 33 | ||||||
non-SCCa | 8 | 33.3 | 50 | ||||||
Pre-treatment Hb (g/dL) | NS | NS | — | — | — | — | |||
≤10 | 16 | 18.8 | 18.8 | ||||||
>10 | 34 | 32.9 | 44.6 | ||||||
Tumor size (cm) | 0.014 | 0.046 | NS | NS | |||||
≤4 | 14 | 40.5 | 53.8 | 1 | 1 | ||||
>4 | 36 | 18.5 | 22.2 | 1.886 (0.777-4.577) | 2.298 (0.839-6.292) | ||||
Treatment type | NS | NS | — | — | — | — | |||
RT + CTx | 39 | 27.2 | 37.4 | ||||||
RT alone | 11 | 32.7 | 32.7 | ||||||
Dissemination pattern | 0.010 | 0.009 | 0.075 | 0.076 | |||||
Group A | 35 | 35.3 | 46.3 | 1 | 1 | ||||
Group B | 15 | 13.3 | 13.3 | 1.954 (0.934-4.090) | 1.962 (0.931-4.136) | ||||